PROMETRA II PROGRAMMABLE PUMP
Report
- Report Number
- 3010079947-2017-00170
- Event Type
- Injury
- Date Received
- November 29, 2017
- Date of Event
- September 22, 2017
- Report Date
- October 30, 2017
- Manufacturer
- FLOWONIX MEDICAL, INC.
- Product Code
- LKK
- UDI-DI
- 00810335020228
- PMA / PMN Number
- P080012
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- NURSE
Narratives
(B)(4). ADDITIONAL INFORMATION WAS RECEIVED FOR COMPLAINT (B)(4).
(B)(4). DEVICE EVALUATION: THE DEVICE WAS SUBJECTED TO VISUAL EXTERNAL AND INTERNAL INSPECTION, AS WELL AS FUNCTIONAL, ELECTRICAL, AND FLOW TESTING. THE EVALUATION DETERMINED THAT THE ISSUE WAS LIKELY CAUSED BY A CHEMICAL INTERACTION OCCURRING BETWEEN AN INTERNAL COMPONENT AND THE DRUG. THE DRUG, VALPROATE, WAS USED DURING A CLINICAL INVESTIGATION WITH THE PUMP. BASED ON THE RESULTS OF THE INVESTIGATION, THE REPORTED EVENT WAS CONFIRMED.
INTERNAL COMPLAINT NUMBER: (B)(4).
IT WAS REPORTED THAT SURGICAL INTERVENTION WAS TAKEN TO EXPLANT THE PUMP.
IT WAS REPORTED THAT THE VOLUME OF UNDELIVERED DRUG REMAINING IN THE DRUG RESERVOIR WAS GREATER THAN THE EXPECTED VOLUME BASED UPON THE PROGRAMMED INFUSION RATE ON FOUR OCCASIONS. PUMP THERAPY IS INTENDED TO TREAT SYMPTOMS ASSOCIATED WITH EPILEPSY WITH 80 MG VALPROATE PER DAY WITH CITRIC ACID AND WITH A DRUG CONCENTRATION OF 150 MG PER ML. THE PATIENT EXPERIENCED INCREASED SEIZURES DURING THE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 847443 | PROMETRA II PROGRAMMABLE PUMP | IMPLANTABLE INFUSION PUMP | LKK | FLOWONIX MEDICAL, INC. | 13827 | 00810335020228 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |